Article
Species selectivity of a nicotinic acetylcholine receptor agonist is conferred by two adjacent extracellular beta4 amino acids that are implicated in the coupling of binding to channel gating.
Molecular pharmacology - 1 Feb 2007
Young Gareth T, Broad Lisa M, Zwart Ruud, Astles Peter C, Bodkin Michael, Sher Emanuele, Millar Neil S
Abstract excerpt
5-(Trifluoromethyl)-6-(1-methyl-azepan-4-yl)methyl-1H-quinolin-2-one (TMAQ) is a novel nicotinic acetylcholine receptor (nAChR) agonist with strong selectivity for beta4-containing receptors. TMAQ also exhibits remarkable species selectivity, being a potent agonist of nAChRs containing the human beta4 subunit but having no detectable agonist activity on nAChRs containing the rat beta4 subunit. With the aim of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
